Inflammation markers in healthy and periodontitis patients. A preliminary data screening

Brazilian Dental Journal

Volumn 19, Issue 1, 2008, Pages 3-8

  de Queiroz, Adriana Corrêa ^a   Taba, Mario ^a   O'Connell, Aquino Patrícia ^a   da Nóbrega, Priscila Brasil ^a   Costa, Paganini Priscila ^a   Kawata, Viviane Keiko dos Santos ^a   Trevisan, Lunardelli Glauce ^a   Novaes, Arthur Belém ^a   de Souza, Sergio Luís Scombatti ^a   Palioto, Bazan Daniela ^a   Grisi, Márcio Fernando de Moraes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarkers; Periodontitis; Serum

Indexed keywords

AUTACOID; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; CCL3 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; CXCL9 CHEMOKINE; CXCL9 PROTEIN, HUMAN; CYTOKINE; FAS LIGAND; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 9; INTERLEUKIN DERIVATIVE; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; GINGIVA BLEEDING; HUMAN; PERIODONTAL DISEASE; PERIODONTITIS;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; CHEMOKINE CXCL9; CHEMOKINES, CC; CHRONIC PERIODONTITIS; CYTOKINES; FAS LIGAND PROTEIN; FIBROBLAST GROWTH FACTOR 2; GINGIVAL HEMORRHAGE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-9; INTERLEUKINS; LYMPHOTOXIN-ALPHA; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; TRANSFORMING GROWTH FACTOR BETA;

EID: 61449320551     PISSN: 01036440     EISSN: 18064760     Source Type: Journal    
DOI: 10.1590/s0103-64402008000100001     Document Type: Article

References (20)

1. Craig RG, Yip JK, Mijares DQ, LeGeros RZ, Socransky SS, Haffajee AD. Progression of destructive periodontal diseases in three urban minority population: role of clinical and demographic factors. J Clin Periodontol 2003;30:1075-1083.
2. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
3. Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acutephase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107:347-352.
4. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 1998;3:127-141.
5. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res 2002;4:233-242.
6. Takahashi K, Takashiba S, Nagai A, Takigawa M, Myoukai F, Kurihara H, et al. Assessment of interleukin 6 in the pathogenesis of periodontal disease. J Periodontol 1994;65:147-153.
7. McGee JM, Tucci MA, Edmundson TP, Serio CL, Johnson RB. The relationship between concentrations of proinflammatory cytokines within gingiva and the adjacent sulcular depth. J Periodontol 1998;69:865-871.
8. Mogi M, Otogoto J, Ota N, Inagaki H, Minami M, Kojima K. Interleukin 1b, interleukin 6, b2-microglobulin, and transforming growth factora in gingival crevicular fluid from huma periodontal disease. Arch Oral Biol 1999;44:535-539.
9. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis - impact on periodontal pathology. J Dent Res 2006;85:15-21.
10. Ishihara Y, Nishirara T, Kuroyanagi T, Shirozu N, Yamagishi E, Oliguchi M, et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontallyhealthy and diseased sites. J Periodontal Res 1997;32:524-529.
11. Machtei EE, Christersson LA, Grossi SG, Dunford R, Zambon JJ, Genco RJ. Clinical criteria for the definition of "established periodontitis". J Periodontol 1992;63:206-214.
12. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-148.
13. Belardelli F, Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. T Immunol 2002;23:201-208.
14. Yucel-Lindberg T, Nilsson S, Modeer T. Signal transduction pathways in-volved in the synergistic stimulation of prostaglandin production by interleukin-1b and tumor necrosis factor a in human gingival fibroblast. J Dental Res 1999;78:61-68.
15. Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalinski K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissu and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30:1046-1052.
16. Appay V, Dunbar PR, Cerundolo V, McMichel A, Czaplewski L, Rowland-Jones S. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner trough cell surface aggregation. Int Immunol 2000;12:1173-1182.
17. Castellani ML, Madhappan B, Salini V, Vecchiet J, Tete S, Frydas S et al. Rantes (CCL5) potentiates calcium ionophore in the production of LTB4 in rat adherent macrophages from granuloma induced by KMnO4: inhibiton by NDGA. Pharmacol Res 2007; accepted manuscript.
18. KwaK HB, Takeshita S et al. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor-B ligand and involved in osteoclast adhesion and migration. Blood 2005;105:2963-2969.
19. Costa GC, Silva RM, Franco-Penteado CF, Antunes E, Ferreira HHA. Interaction between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils Eur J Pharmacol 2007;566:200-205.
20. Mir A, Minguez M, Tatay J, Pascual I, Pena A, Sanchiz V et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastro 2002;97:1452-1457.